Drugs / Haloperidol Decanoate
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | HALDOL | — | 1986-01-14 | fda.gov ↗ |
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT04327843 | Nov 2019 → Jul 2020 | schizoaffective disorder, schizophrenia | Case Western Reserve University | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00018642 | Apr 1997 → Mar 2002 | schizoaffective disorder, schizophrenia | US Department of Veterans Affairs | Completed | No outcome recorded |
| Comparator or background therapy3 trials | ||||||
| Phase 2 | NCT01949662 Background | Jan 2014 → Aug 2016 overdue | high grade malignant neoplasm | M.D. Anderson Cancer Center | Active not recruiting | Met primary |
| Phase 4 | NCT01136772 Comparator | Mar 2011 → Jul 2013 | schizoaffective disorder, schizophrenia | New York State Psychiatric Institute | Completed | Missed primary |
| Phase 4 | NCT00947375 Background | Jan 2005 → Jan 2006 | schizophrenia | Central Mental Clinic for Outpatients of Baku City | Terminated | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | haloperidol decanoate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01136772 ↗ |
| Known as | Haldol dec | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200986 ↗ |
| Known as | Halomonth | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200986 ↗ |
| Known as | R-13,672 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200986 ↗ |
| Action | Inhibit | “Serotonin 2a (5-HT2a) receptor antagonist” CHEMBL1200986 ↗ |
| Modality | Small molecule | — CHEMBL1200986 ↗ |
| Route | Intramuscular | “haloperidol deaconate 50 mg in weekly intramuscular” NCT00947375 ↗ |
| Target | HTR2A | “Serotonin 2a (5-HT2a) receptor antagonist” CHEMBL1200986 ↗ |